Legal Advantage Investments, Inc. Bristol Myers Squibb CO Transaction History

Legal Advantage Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $42,375 - $47,382	-732 Reduced 16.06%	3,825 $222,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $31,855 - $35,370	-500 Reduced 9.89%	4,557 $291,000
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $59 - $35,269	459 Added 9.98%	5,057 $360,000
Q1 2022 May 06, 2022	BUY	$61.48 - $73.72 $12,173 - $14,596	198 Added 4.5%	4,598 $336,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $235,972 - $275,088	4,400 New	4,400 $274,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Legal Advantage Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Legal Advantage Investments, Inc. with notifications on news.